Finerenone and Kidney Outcomes in Patients with Heart Failure: The FINEARTS-HF Trial
医学
心力衰竭
内科学
重症监护医学
心脏病学
作者
Finnian R. Mc Causland,Muthiah Vaduganathan,Brian Claggett,Ian J. Kulac,Akshay S. Desai,Pardeep S. Jhund,Alasdair D Henderson,Meike Brinker,Robert Perkins,Markus F. Scheerer,Patrick Schloemer,Carolyn S.P. Lam,Michele Senni,Sanjiv J. Shah,Adriaan A. Voors,Faı̈ez Zannad,Bertram Pitt,John J.V. McMurray,Scott D. Solomon
Finerenone has kidney protective effects in patients with chronic kidney disease (CKD) with type 2 diabetes, but effects on kidney outcomes in patients with heart failure (HF) with and without diabetes and/or CKD are not known.